Immuneering Corporation Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Immuneering Corporation stock issued during period, value, employee stock purchase plan for the quarter ending 2026-03-31 was $170.32K, a 27.21% increase year-over-year.
- Immuneering Corporation stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $288.02K, a 126.45% increase year-over-year.
- Immuneering Corporation stock issued during period, value, employee stock purchase plan for the quarter ending 2025-03-31 was $133.89K, a 45.89% decline year-over-year.
- Immuneering Corporation stock issued during period, value, employee stock purchase plan for the quarter ending 2024-09-30 was $127.19K.
- Immuneering Corporation stock issued during period, value, employee stock purchase plan for fiscal 2025 was $421.91K, a 12.61% increase from fiscal 2024.
- Immuneering Corporation stock issued during period, value, employee stock purchase plan for fiscal 2024 was $374.65K.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-03-31 | $170.32K 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $421.91K 10-K · filed 2026-03-06 | |
| 2025-09-30 | $288.02K 10-Q · filed 2025-11-12 | |
| 2025-03-31 | $133.89K 10-Q · filed 2026-08-05 | |
| 2024-12-31 | $374.65K 10-K · filed 2026-03-06 | |
| 2024-09-30 | $127.19K 10-Q · filed 2025-11-12 | |
| 2024-03-31 | $247.47K 10-Q · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |